Acute Myocardial Infarction
544
40
57
295
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
38 trials with published results (7%)
Research Maturity
295 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
27 terminated out of 544 trials
91.6%
+5.1% vs benchmark
19%
106 trials in Phase 3/4
13%
38 of 295 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 295 completed trials
Clinical Trials (544)
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)
Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
STEMI Cool Pilot Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI (Phase A)
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
Acute Myocardial Infarction Clinical Cohort
SUBDIMA: Subclinical Depression in Acute Myocardial Infarction (SUBDIMA25)
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
Ticagrelor Monotherapy After Stenting
EXCELLENT (EXpanded CELL ENdocardiac Transplantation)
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes
Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE
Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease
Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction
Thrombus and Inflammation Study in Sudden Cardiac DEath
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration